July/August 2011 Issue
A Milwaukee newspaper reminds an industry of its flaws.
The challenge all quality professionals face is answering the question, How much is enough?
We are more easily led part by part to an understanding of the whole. Seneca
Mike Ponstingl, owner of Custom Sensors & Technology, shares insight into new methods of monitoring fermentation and other bioprocesses.
Pharma could learn a few lessons in accountability and respect.
As its auto industry has done, Japan pharma may demonstrate that a cheaper manufacturing base is not necessarily the solution to our problems.
Organizations with built-in risk management frameworks allow middle managers to thrive, says Scott Chizzo, Maxiom Groups president and chief consultant, in this exclusive interview.
Pharma's middle managers carry on despite a "damned if we do, damned if we don't" environment.
Middle managers in pharma today have a tough, thankless jobbut someones got to do it, and many do it well.
What was once a laborious process is getting easier, thanks to modern sensors and calibration procedures.
Reader response from last month's Editor's letter.
Probabilistic rather than deterministic modeling is essential, says Quintiles Davis Walp.
Facebook is going back on its pledge for full transparency and giving pharma companies the option to turn off their wall feature if pages meet specific criteria, thus hindering users from commenting publicly.
IT compliance today requires a paradigm shift from a project-specific engagement to a comprehensive, centralized compliance program.